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Background. Transfection eﬃcacy after nonviral gene transfer in primary epithelial cells is limited. The aim of this study was to
comparetransfectioneﬃcacyoftherecentlyavailablemethodofnucleofectionwiththeestablishedtransfectionreagentFuGENE6.
Methods. Primary human keratinocytes (HKC), primary human ﬁbroblasts (HFB), and a human keratinocyte cell line (HaCaT)
were transfected with reporter gene construct by FuGENE6 or Amaxa Nucleofector device. At corresponding time points, β-
galactosidase expression, cell proliferation (MTT-Test), transduction eﬃciency (X-gal staining), cell morphology, and cytotoxicity
(CASY) were determined. Results. Transgene expression after nucleofection was signiﬁcantly higher in HKC and HFB and detected
earlier (3 h vs. 24 h) than in FuGENE6. After lipofection 80%–90% of the cells remained proliferative without any inﬂuence
on cell morphology. In contrast, nucleofection led to a decrease in keratinocyte cell size, with only 20%–42% proliferative cells.
Conclusion. Related to the method-dependent increase of cytotoxicity, transgene expression after nucleofection was earlier and
higher than after lipofection.
Copyright © 2006 Frank Jacobsen et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
The development of gene carriers for eﬃcient gene deliv-
ery into cells has attracted growing attention in the recent
years. Cutaneous expression can be achieved by genetic ma-
nipulation of epidermal keratinocytes ex vivo followed by
transplantation or by local delivery of corresponding vec-
tors [1]. Experimental evidence shows that genetically engi-
neered skin can produce and secrete medically relevant pro-
teins to the circulation and also produce enzymes that can
clear metabolites accumulating in various diseases [2]. Thus,
cu t an eo usg e n etran s f e rap p r oac h esm a yber el evan tn o to n l y
for local skin diseases, but also for certain systemic disorders
[3, 4].
Virus-mediated delivery of genes is more eﬃcient than
plasmid-mediated delivery, but safety concerns regarding
immunogenicity, oncogenic properties, risk of recombina-
tion with wild-type viruses, and unknown long-term eﬀects
remain problematic for its potential clinical use [5]. Another
disadvantage of many viral vectors is their limited capacity
fordeliveringlargeforeigngenes.Moreover,viralvectors(eg,
AAV, adenovirus, and retrovirus) are diﬃcult to prepare, ex-
pensive, and potentially hazardous to work with. Nonviral
vectors on the other hand do not have such safety concerns.
They remain in a nonreplicative episomal form, have low
immunogenicity, and are easy and safe to prepare and use.
Furthermore,plasmidsmayaccommodatelargefragmentsof
DNA [6].
In contrast to most viral systems, plasmids provide tem-
porary expression of the transfected gene [7]. In order to
transfect cells successfully, it is important to overcome the
natural barrier of cytoplasmic and nuclear membranes to
deliver the genetic material into the cytoplasm or the nu-
cleus. These techniques are categorized into three general
groups: direct injection of naked DNA [8], the delivery by
a physical method, such as electroporation [9], gene gun
[10], microseeding [11], or nucleofection, or mediated by
a chemical carrier such as cationic polymers and lipids
[12].
The use of these gene delivery methods strictly depended
on the kind of target cells, the method of application (eg, if
in vivo, ex vivo or in vitro), and the cellular environment.
Compared with other tissues, skin oﬀers the advantage
of being easily accessible for manipulations and monitoring.
In addition, skin ﬁbroblasts and keratinocytes are interesting
candidates for this purpose since they are well-studied pri-
mary cells and are relatively easy to isolate and grow in vitro
[13],thuspermittingself-renovatingepithelialtransplantsby
procedures currently used in the treatment of burns or other
cutaneous disorders [14].2 Journal of Biomedicine and Biotechnology
Epidermal keratinocytes are also potentially useful for
the production of biologically active factors or polypeptides
(eg, growth factors and host defense peptides) for systemic
or local delivery to treat inherited or acquired disorders
[15, 16]. For cutaneous gene delivery, techniques must be re-
producible, not toxic, and highly eﬃcient to show a biologic
eﬀect. The Amaxa nucleofection technique is a variation of
electroporationtailoredforcertaincelltypes.Thiselectropo-
ration technique has previously shown its transfection eﬃ-
cacy for various primary cells and hard-to-transfect cell lines
[17–21].
The goal of this study was to analyze transfection eﬃcacy
of reporter genes, cytotoxicity, and cell morphology with nu-
cleofection or cationic transfection reagents in primary hu-
man keratinocytes, ﬁbroblasts, and the immortalized ker-
atinocyte cell line HaCaT.
MATERIAL AND METHODS
Cellculture
Freshly received human skin was washed in PBS (PAA Labo-
ratories, H 15002, Linz, Austria) and digested overnight with
0.2% dispase-solution (4,7U/mL, Gibco, 17105-041, Pais-
ley, UK). Epidermis was gently peeled oﬀ, collected directly
into Trypsin/EDTA solution (0.05%/0.02%, Gibco, 35400-
027, Paisley, UK), and incubated at 37
ÆCf o r5m i n u t e s
in a gently shaking water bath. The remaining dermis was
used for the isolation of ﬁbroblasts as described below. Af-
ter trypsin digestion was stopped by adding FBS (HyClone,
Logan, USA), the cell suspension was ﬁltered through a 100-
μm cell strainer (Becton Dickinson Heidelberg, Germany)
and centrifuged at 400
￿ g, 4
ÆC for 5 minutes. Cells were re-
suspended in 5mL complete keratinocyte medium (contain-
ing 3 : 1 DMEM (Gibco, 21969-035, Paisley, UK)), Ham’s
F12 (Gibco, 21765-029, Paisley, UK), 10% FBS (Hyclone,
Logan, USA), 1% penicillin/streptomycin (ICN, Aurora,
USA), 4mM L-glutamin (ICN, Aurora, USA), 24.3mg/L
adenine (Calbiochem, Darmstadt, Germany), 5mg/L In-
sulin (Sigma, St Louis, USA), 0.4mg/Lhydrocortisone(Cal-
biochem, Darmstadt, Germany), 1.36μg/L triiodothyronine
(Sigma, St Louis, USA), 10
 10 M cholera toxin (Sigma, St
Louis, USA), and 10μg/L EGF (Sigma, St Louis, USA) and
counted by CASY-1 (Sch¨ arfe-System, Reutlingen, Germany).
Culture ﬂasks precoated with collagen type I were seeded
with 75 000 cells/cm2 (Becton Dickinson Falcon, 354236,
Heidelberg, Germany). Medium was changed every second
day.
Isolationofhumanﬁbroblasts
Excessive dermis from isolation of keratinocytes was washed
in PBS (PAA Laboratories, H 15002, Linz, Austria) and
weighed in a sterile 50-mL tube. The appropriate amount
of sterile ﬁltered collagenase type II (Gibco, Paisley, UK)
was added and incubated for 6 hours at 37
ÆCi nar o -
tor oven (Bachofer, Reutlingen, Germany). Dissolved der-
mis was ﬁltered through a 100μm cell strainer (Becton
Dickinson, Heidelberg, Germany) and centrifuged at 400
￿
g, 4
ÆC, for 10 minutes. Cells were resuspended in ﬁbrob-
last medium (containing DMEM (Gibco, 21969-035, Pais-
ley, UK)), 10% fetal bovine serum (Hyclone, Logan, USA),
1% penicillin/streptomycin (ICN, Aurora, USA), and 4mM
L-Glutamin (ICN, Aurora, USA) and seeded at a density of
25000cells/cm2.Primaryhumanﬁbroblastswereculturedat
37
ÆC in a humidiﬁed atmosphere of 5% CO2, and medium
was changed every second day.
Plasmidpreparation
Endotoxin-free Plasmid Puriﬁcation Kit (Qiagen, Hilden,
Germany)wasusedaccordingtomanufacturer’sinstructions
topurifypCMVβgalcodingforβ-galactosidaseofEscherichia
coli and pEGFP-N1 coding for enhanced green ﬂuorescence
protein (both Clontech, Heidelberg, Germany). DNA was
measuredphotometricallyatawavelengthof260nmandcal-
culated in μg/mL.
LipofectionwithFuGENE6
Cells were seeded at 100 000cells/cm2 (primary keratino-
cytes), 52 000cells/cm2 (primary ﬁbroblasts), and 50000
cells/cm2 (keratinocyte cell line) in a 6-well plate one day be-
fore transfection. The next day, medium was replaced with
1mL fresh medium. Three parts FuGENE6 were mixed with
two parts plasmid DNA for a ﬁnal amount of 3μgD N A / w e l l .
After 15 minutes of incubation at room temperature, the
mixture was added to the cells and further incubated for 6
hours at 37
ÆC, 5% CO2. Medium was then changed and in-
creased to standard volume.
NucleofectionwithAmaxa-Nucleofector
The same number of cells as described for lipofection was re-
suspendedincorrespondingnucleofectorsolution.DNAand
cells were mixed in the Amaxa cuvette and directly placed in
the nucleofector device.
Primaryhuman keratinocytes weretreatedwithprogram
T-24, human ﬁbroblasts with U-23, and HaCaT cells with
the program U-20. Each program used has been optimized
and recommended by the manufacturer. Cell suspension
was removed immediately from the cuvette by adding pre-
warmed medium with the Amaxa pipette. Cell suspension
was added to a 6-well plate containing prewarmed medium
and incubated at 37
ÆC, 5% CO2, in a humidiﬁed atmo-
sphere.
β-Galactosidaseassay
Medium was removed and cells were rinsed twice with PBS.
Lysis solution was added and a cell scraper was used to de-
tach the cells. Lysed cells were pipetted up and down sev-
eral times. Lysates were centrifuged at 14 000rpm, 4
ÆC, for 2Frank Jacobsen et al 3
minutes (Eppendorf centrifuge 5402, Hamburg, Germany),
and the supernatant was snap-frozen in liquid N2 and stored
at
￿80
ÆC until use.
The Galacto-Light-Plus assay (Tropix, Lincoln, USA)
was performed according to the manufacturer’s instructions.
Brieﬂy, β-galactosidase standards and cell lysates were trans-
ferred to a white 96-well plate and incubated with reac-
tion buﬀer for 30 minutes at room temperature. The injec-
tion unit of the microplate luminometer (Berthold, Orion,
Pforzheim, Germany) added the accelerator solution auto-
matically, and the signal was measured for 1 second. The ﬁ-
nal amount of β-galactosidase in each sample was evaluated
by parallel measured β-galactosidase standard (20ng–256fg
in a serial dilution).
BCAassay
To determine the total amount of protein, a BCA protein
assay (Pierce, Rockford, USA) was applied according to the
manufacturer’s protocol, using bovine serum albumin (BSA)
as the standard (Pierce, Rockford, USA). In brief, standards
and lysates were incubated with working reagent at 37
ÆC
for 30 minutes. The absorbance was measured at 562nm in
a microplate ELISA reader (ELX 808, Bio-Tek Instruments,
Winooski, USA). The concentrations were determined by a
BSA standard curve.
X-galstaining
Forty-eight hours after transfection, medium was removed,
and the cells were washed with PBS. Fixation solution was
added for 5 minutes at room temperature, and cells were
washed again with PBS. After X-gal staining solution
(1mg/mLX-gal;5mMK3Fe(CN)6;5mMK 3Fe(CN)6;1mM
MgCl2; phosphate-buﬀered saline pH 7.4) was added, cells
were incubated for 6 hours at 37
ÆC. Transfection eﬃciency
was assessed by determining the number of positive cells ver-
sus total number of cells in 10 high-power ﬁelds (magniﬁca-
tion 200
￿).
MTTtest
Twenty-fourhoursaftertransfection,MTT(methylthiazolyl-
diphenyl-tetrazolium bromide, Sigma Aldrich, Taufkirchen,
Germany) was added for 1 hour at 37
ÆC. Medium was re-
moved and cells were lysed by pipetting up and down with
500μL/well 0.01N HCL +10% SDS (sodium lauryl sulfate,
Sigma Aldrich, Taufkirchen, Germany). The lysates were
transferred to a 96-well plate and measured at 562nm us-
ing an ELISA plate reader (ELX808, BioTek Instruments,
Winooski, USA). The number of proliferative cells was cor-
related with the negative control (100% survival).
CASYsystem
For analysis of cell morphology, both transfection methods
were performed with and without DNA and then compared
with untreated cells. Cells were washed with PBS and de
tached by incubation for 5 minutes at 37
ÆC with tryp-
sin/EDTA (0.05%/0.02%, PAA Laboratories, Linz, Austria).
Cell suspension was diluted 1 : 1000 with CASY Ton (Sch¨ arfe
System, Reutlingen, Germany) in CASY cups and measured
by CASY device. This system counts the amount of cells per
volume and calculates the median dimension of the cells by
measuring the resistance of the used cell suspension.
Statisticalanalysis
All assays were performed in triplicate. Results were cal-
culated in Excel and were statistically evaluated with the
software program SPSS 11.0 (SPSS Inc, Chicago, USA). Re-
sults were regarded as signiﬁcant with P<. 05.
RESULTS
Transgeneexpression
To analyze the transfection eﬃcacy, β-galactosidase expres-
sion was determined in correlation to the total protein.
Nucleofection induces high transgene expression rates in
primary human keratinocytes (HKC) and ﬁbroblasts (HFB).
In primary human ﬁbroblasts gene expression could be mea-
sured 12 hours after lipofection, whereas transgene expres-
sion was detectable after 3 hours and peaked after 72 hours
if nucleofection was used. Lipofection also produced a max-
imum value at 72 hours (39ng/mg total protein) that was
15 times lower than the expression values of nucleofected
cells (600ng/mg total protein) (Figure 1). Transgene expres-
sion decreased drastically to background level for nucleo-
fected ﬁbroblasts between days 3 and 5. During the whole
time course, lipofection demonstrated an even progression.
The progression curve of transgene expression demon-
strated lower acclivity for human primary keratinocytes
than for primary ﬁbroblasts. The measured β-galactosidase
peaked after 72 hours at a level 7 times higher with nucleo-
fectionthanwithFuGENE6(198ng/mgvs27ng/mg).Trans-
geneexpressionalsoproceededmoderatelyanddidnotreach
background level until day 5.
InthehumankeratinocytecelllineHaCaT,onlyalowex-
pression rate was achieved with both techniques. Lipofection
gene expression was detectable after 12 hours. In contrast
to the lipofection, which reached peak value after 24 hours
(max 7ng/mg total protein), the expression after nucleofec-
tion increased continuously until 72 hours (max 10ng/mg
total protein). Expression level was signiﬁcantly (P<. 05)
higher for lipofection between days 1 and 2, whereas nucleo-
fection achieved signiﬁcantly (P<. 05) higher transgene ex-
pression at days 3 and 5 (Figure 1).
Transfectionefﬁciency
The number of β-galactosidase-producing cells was deter-
mined with X-gal staining and high-power ﬁeld (HPF)
calculation. The calculated transgene-expressing cells were4 Journal of Biomedicine and Biotechnology
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Figure 1: Transfection eﬃcacy. Reporter gene expression in epithe-
lial cells (5 days followup). FuGENE6-enhanced lipofection (open
triangle) and Amaxa nucleofection techniques (open square) were
compared. Each measured value including the HaCaT curve was
upon background levels. #: (P<. 05) nucleofection versus lipofec-
t i o n ,+ :( P<. 05) lipofection versus nucleofection. Data are dis-
played as mean
￿ SEM.
related to the total number of used cells. A transfec-
tion rate of 5% could be demonstrated for human ker-
atinocytes and 10% for human ﬁbroblasts, whereas the
human keratinocyte cell line achieved only 0.5%. For all
cases nucleofection demonstrated signiﬁcantly (P<. 05)
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Figure 2: Histological analysis. The transfection eﬃcacy of the
FuGENE6-enhanced lipofection (white bars) and the Amaxa nu-
cleofection techniques (black bars) are displayed. X-gal stained cells
were counted in 10 high-power ﬁelds (HPF) at 200-fold magniﬁca-
tion and extrapolated on positive cells/well. Positive cells were cor-
related to the number of cells used per well. #: (P<. 05) nucleofec-
tion versus lipofection. Data are displayed as mean
￿ SEM.
higher transfection eﬃciency than the FuGENE6 lipo-
fection method (Figure 2). Diﬀerences in cellular mor-
phology were not seen after X-gal staining (Figure 3).
Cell survival was lower for nucleofection than for lipo-
fection. However, only small cell islands were observed
48 hours after nucleofection, whereas a conﬂuent mono-
layer was established at the same time-point after lipofec-
tion.
Cellviability
Comparing the eﬀect of both transfection methods on
cell viability, the activity of mitochondrial dehydrogenase
was determined by MTT test. The cell toxicity induced
by the corresponding application was measured for the
method alone or together with DNA. This assay revealed
high cell viability after FuGENE6 lipofection. The re-
sults demonstrated a signiﬁcant diﬀerence in applying Fu-
GENE6 transfection only for HaCaT cells. After lipofec-
tion, 75% of HaCaT cells, 85% of keratinocytes, and 99%
of ﬁbroblasts were still proliferating. Nucleofection, how-
ever, revealed a proliferation rate 22% for HaCaT cells,
23% for keratinocytes, and 37% for ﬁbroblasts. Within
all experimental groups lipofection resulted in a signiﬁ-
cantly (P<. 05) higher proliferation rate than nucleofec-
tion. In addition, HaCaT cells demonstrated a signiﬁcant
(P<. 05) decrease of proliferation if DNA was applied
(Figure 4).
The cells were analyzed by CASY system to determine
whether cell morphology was dependent on the transfec-
tion method applied with or without DNA. This system
permits determination of cell count and diameter and vol-Frank Jacobsen et al 5
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Figure 3: Cellular morphology. X-gal stained primary ﬁbroblasts (a) and (d), primary keratinocytes (b) and (e), and HaCaT cells (c) and (f).
Lipofection (a)–(c) and nucleofection techniques (d)–(f) were compared. Pictures were selected to demonstrate typical positively stained
cells for both techniques. Pictures shown are not representative in comparison with the corresponding HPF counting of Figure 2 (Bar
represents 100μm, magniﬁcation 200
￿).
ume of the cells. Lipofection revealed moderate diﬀerences
between treated and untreated cells. In general, the re-
sulting curves were similar in appearance, with no sta-
ble change in cell diameters and cell counts. On the other
hand, nucleofection showed an adjustment of the distribu-
tion curve to lower counts for all tested cell types. Fur-
ther diﬀerences were observed in keratinocytes, if DNA was
applied, compared with the nucleofection technique alone.
With DNA, nucleofection produced smaller cell diameters
(Figure 5).
DISCUSSION
Transient cutaneous gene therapy might be an impor-
tant treatment option in the near future for wound re-
pair and regeneration [10, 22, 23], but reliable methods
are needed to achieve a level of transgene expression that
shows a reproducible biologic eﬀect. In this report, appli-
cability of nucleofection technology for the transient trans-
fection of ﬁbroblasts and keratinocytes is demonstrated.
We are considering the application of ex vivo-transfected
primary cells as an attractive method for wound healing
[14]. For conventional transfection methods such as cal-
cium phosphate-mediated transfection, lipofection, or elec-
troporation, exponentially growing cells were recommended
[17, 24], in contrast to nucleofection, in which the prolifera-
tion status of the cells has very little impact on the transfec-
tion eﬃcacy.
In fact, the transfection eﬃcacy with a maximum of 9%
for primary ﬁbroblasts seems to be low. According to the
calculation that determined 1%–9% of positive cells, com-
pared with the number of cells used for each experiment
and according to the level of about 20%–40% surviving cells,
the transfection eﬃcacy correlated to 5%–25%. Higher per-
centages of transgene-positive keratinocytes have been re-
portedafternucleofection,butinthesecasescellsweretrans-
fected with eGFP-encoding plasmids and results were deter-
mined by FACS analysis, which is indisputably the more sen-
sitive technique [25], whereas quantiﬁcation with biolumi-
nescence is much more sensitive for β-galactosidase. How-
ever, in comparison with viral gene delivery techniques, the
transfection rate with nucleofection was moderate, but on a
high level if nonviral techniques were taken into considera-
tion [26].6 Journal of Biomedicine and Biotechnology
The discrepancy between nucleofection (3 hours) and
lipofection (24 hours) at the onset of transgene expres-
sion may depend on the additional barrier of the nuclear
membrane that lipofection has to circumvent before trans-
gene expression starts. The diﬀerences in the level of expres-
sion after nucleofection and lipofection likely arise from the
fact that gene expression is a time-dependent process. In-
deed, as soon as the plasmid reached the nucleus directly,
β-galactosidase level increased immediately. Furthermore,
sinceβ-galactosidaseisastableproteinwithahalf-lifegreater
than 24 hours in cells [27], the levels of β-galactosidase
should remain higher in nucleofected cells than in lipofected
cells at all times because the DNA is available to the tran-
scription machinery for a longer time. A strong increase of
transgene expression was observed in ﬁbroblasts before day
3, followed by a drastic decrease between days 3 and 5. This
increase may be caused by promoter silencing, intracellular
transcript inhibition, or plasmid degradation.
After transfection, proliferation of primary keratinocytes
was stronger than that of HaCaT cells, which may be related
to the diversiﬁcation of primary cell population; neverthe-
less, the involved mechanism is still unclear. None to mod-
erate inhibition of proliferation was shown for FuGENE6-
enhanced transfection. The survival rate of primary human
skin ﬁbroblasts treated with 3μL FuGENE6 has been re-
ported in the literature at 86% [28]. Transfection leads to
cyclearrest of metabolically active transfectedcells(those ex-
pressing the transgene), which is not caused by transgene ex-
pression per se, but is due to an indirect eﬀect of the exoge-
nous DNA [29]. It has also been shown that higher amounts
of foreign DNA lead to a decrease of proliferating and colo-
nizing keratinocytes [24]. The data from our study showed
a remarkable variation between primary keratinocytes and
the HaCaT cell line. HaCaT cells are often used as a stan-
dard in vitro model to investigate cutaneous processes, be-
cause of their availability, genetic homogeneity, and compa-
rable behavior to primary keratinocytes [30–32]. However,
we have strong evidence that primary keratinocytes and the
HaCaT cell line are not biologically comparable. There was
an obvious diﬀerence in cellular morphology and prolifera-
tion when lipofection or nucleofection was used. This ﬁnd-
ing will be of relevance if nucleofection is used as a stan-
dardized ex vivo transfection system. The obvious diﬀer-
ences in cellular morphology shown by the pictures of X-
gal staining are due to methodical diﬀerences. For the nu-
cleofection method, detached cells were transfected, wheras
attached cells were transfected with the lipofection method.
No further diﬀerences could be detected between the tech-
niques, but the CASY system showed a shift to lower cell
diameters after nucleofection of primary keratinocytes. Cell
fusion resulting in polynucleated cells was not observed any-
where. Since the nucleofection technology facilitates transfer
ofDNAdirectlyintothecell’snucleus,itpermitstransfection
of a wide variety of primary cells and cell lines, which prolif-
erate slowly or are amitotic. Thus, this technology allows the
selection of a cell type for gene transfer according to its bio-
logical signiﬁcance rather than to its division rate. It allows
experiments of higher biological relevance in many ﬁelds of
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Figure 4: Proliferation. MTT test was performed to analyze the cy-
totoxic side eﬀects of lipofection (striped) and nucleofection tech-
niques (black). The additional cytotoxic eﬀect of plasmid DNA was
determined to distinguish these techniques further. Proliferation
control was set at 100%. #: (P<. 05) nucleofection versus lipo-
fection;
￿:( P<. 05) nucleofection (+) DNA versus nucleofection
(
￿)D N A ;+ :( P<. 05) lipofection (+) DNA versus lipofection (
￿)
DNA. Data are shown as mean
￿ SEM.
basic research and may be of value in gene-transfer-based in-
dustrial approaches, such as functional genomics, gene ther-
apy research, and the development of ex vivo protocols, es-
pecially if transient expression is desired.Frank Jacobsen et al 7
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Figure 5: CASY Analysis. Nucleofection (upper panels) and lipofection (lower panels) were correlated by CASY system. Each cell type was
t r e a t e dw i t h( r e d )o rw i t h o u t( g r e e n )D N A .U n t r e a t e dc e l l ss e r v e da sc o n t r o l( b l a c k ) .C e l lc o u n t s(y axis) were plotted against the correlated
diameter (μm, x axis). The ﬁrst peak (5–7μm) represents the amount of cell debris. Further peaks of higher cell diameter within the same
plot refer to diﬀerent levels of cell diﬀerentiation. A diﬀerence of cell diameter was measured only for nucleofected primary keratinocytes.
Data are shown as mean SEM.
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